TRITON2: A Multicenter, Open-label Phase 2 Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer Associated With Homologous Recombination Deficiency
Phase of Trial: Phase II
Latest Information Update: 12 Aug 2017
At a glance
- Drugs Rucaparib (Primary)
- Indications Prostate cancer
- Focus Registrational; Therapeutic Use
- Acronyms TRITON2
- Sponsors Clovis Oncology
- 10 Jun 2017 Biomarkers information updated
- 01 Feb 2017 According to a Clovis Oncology media release, Clovis Oncology, Inc. and Strata Oncology, Inc. today announced an agreement to accelerate patient identification and enrollment in this trial.
- 15 Dec 2016 Status changed from not yet recruiting to recruiting.